Norcliffe Capital: Investment Portfolio & Startup News

Norcliffe Capital

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

1 Jul 2025

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

Laverock Therapeutics is developing programmable gene control technologies that enable advanced therapies to respond dynamically to disease, improving precision, safety and effectiveness in cell-based treatments.

Norcliffe Capital

- Life Sciences
norcliffe.capital
Update Information

More venture news

Medcotec
15 Oct 2026
Medcotec announces its £2.4m seed round from VCs to help pharma manufacturers transfer powders with single-use valves
SeedLife Sciences
Silvia Bio
15 Oct 2026
Silvia Bio raises a £3m seed round led by Northern Gritstone to improve complex biopharmaceutical manufacturing
SeedLife Sciences
Alchera Technologies
13 Oct 2026
Alchera Technologies raises a £2.7m seed round led by Maven Capital Partners to analyse transport network data with AI
SeedMobility

Norcliffe Capital: Investment Portfolio & Startup News

Investment Portfolio

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

More venture news

Medcotec announces its £2.4m seed round from VCs to help pharma manufacturers transfer powders with single-use valves

Silvia Bio raises a £3m seed round led by Northern Gritstone to improve complex biopharmaceutical manufacturing

Alchera Technologies raises a £2.7m seed round led by Maven Capital Partners to analyse transport network data with AI